Manufacture of sterile medicinal products
Revised sterile guidance — contamination control strategy
Regulatory Reference
EU GMP Guide
EudraLex Volume 4 — EU Good Manufacturing Practice for medicinal products and active substances, including PIC/S alignment and inspection expectations.
Structure of EudraLex Volume 4
The EU GMP guide is the primary quality standard for manufacturing authorised medicines in the European Union. It is applied by national competent authorities and underpins GMP certificates and Qualified Person (QP) batch release.
| Part | Scope | Chapters (examples) |
|---|---|---|
| Part I | Finished medicinal products | Pharmaceutical Quality System (Ch.1), personnel, premises, equipment, documentation, production, QC, complaints, self-inspection |
| Part II | Active substances (APIs) | Aligned with ICH Q7 — supplier qualification, change control, repackaging/relabeling |
| Annexes | Specialised dosage forms & topics | Sterile, biologicals, radiopharmaceuticals, ATMPs, computerized systems, validation |
Part I — core principles
- Pharmaceutical Quality System — ICH Q10 principles embedded in Chapter 1
- Risk management — ICH Q9 applied to contamination, mix-ups, and cross-contamination
- Documentation & data integrity — ALCOA+ attributes; Annex 11 for electronic systems
- Deviation, CAPA, change control — documented quality system elements inspected routinely
- Qualified Person — certifies each batch before release to EU market (Annex 16)
Key annexes
Manufacture of biological medicinal products
Cell banks, viral safety, in-process controls
Computerised systems
CSV, audit trails, data integrity expectations
Qualification and validation
V-model, CQV lifecycle, ongoing verification
QP certification and batch release
EU batch certification before market release
Sampling of starting and packaging materials
Representative sampling and identity testing
EU vs FDA CGMP — high-level map
| Topic | EU | US FDA |
|---|---|---|
| Quality system | PQS (ICH Q10 in EU GMP Ch.1) | 21 CFR 210/211; ICH Q10 in guidance |
| Sterile manufacturing | Annex 1 (EU) | 21 CFR 211 + aseptic guidance |
| Batch release | QP certification required | QA release; no QP role |
| API GMP | Part II / ICH Q7 | ICH Q7 guidance |
PIC/S participates in harmonising GMP interpretation — many EU and FDA inspection themes overlap (data integrity, contamination control, validation lifecycle).
Frequently asked questions
EU GMP applies when manufacturing for the EU market or when EU authorities inspect global sites
in a MA context. US-only products follow FDA CGMP, though many sponsors align to both for global supply chains.
The revised Annex 1 emphasises contamination control strategy (CCS), holistic sterile design, and
modernised language on isolators, RABS, and visual inspection — replacing the 2008 version for sterile products.